Karwa SARS-CoV-2 Nucleic Acid Detection Kit - India CDSCO Medical Device Registration
Karwa SARS-CoV-2 Nucleic Acid Detection Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000004_1d140ff449b0083a04f0a229d0156b60_27c8b4c3cfdf7696809f6d613559dad2. This device is marketed under the brand name Bivalent. The license holder is KARWA ENTERPRISES PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
Bivalent
License Holder
KARWA ENTERPRISES PRIVATE LIMITEDDevice Class
Approving Authority
CDSCO -North Zone, Ghaziabad
Product Information
For qualitative detection of nucleic acid from SARS-CoV-2 in oropharyngeal swab, nasopharyngeal swab or deep cough sputum specimens
Malaria Pf Antigen Rapid Test
Syphilis Rapid Strip Test
Drugs of Abuse Rapid Test
Dengue NS1 ELISA Test Kit
HCV Rapid Card Test Kit
Syphilis Rapid Card Test
Typhoid Antigen Rapid Card Test
Syphilis ELISA Kit
KARWA COVID-19 RT-LAMP DIAGNOSTIC KIT
HIV ELISA Test Kit
Brand: 3rd Generation